₹23.86
−4.06%NSE close, 16 Nov 2026
−74.69%
Fischer Medical Ventures is a small cap company, listed on NSE under the symbol FISCHER. At ₹23.86 a share, the market values the whole company at ₹1,562 crore.
In FY26, it reported sales of ₹309 crore and a net profit of ₹31 crore, an operating margin of 14.0%.
The market values the company at 3.35 times its book value; its return on equity is -0.5% and its borrowings are 0.11 times its equity.
Promoters hold 63.08% of the shares, and have pledged 6.8% of their holding. Foreign institutions hold 6.71%, and domestic institutions, mutual funds among them, 1.26%.
Over the past year the share price has fallen 75.3%, and it is 75.7% below its 52-week high.
₹ crore. Consolidated figures.
The financial results for the period ended September 30, 2026.
Monitoring agency report for the Quarter ended 30th September 2026 is enclosed
Has informed that Mr. Chan Sing En has been appointed as an Independent Director on the Board of Directors of FMV Global Innovations Pte. Ltd., Singapore, an unlisted material wholly owned subsidiary of the Company, with effect from 27.10.2026 (Today).
Dispatch of Postal Ballot Notice dtd 14th October 2026, to Shareholders
Outcome of Board Meeting held on October 14, 2026.
| 107 |
| Expenses | 19.2 | 70.1 | 79.5 | 96.7 | 70.7 | 98.5 |
|---|
| Operating profit | 4.3 | 16.3 | 21.6 | 1.0 | 11.3 | 8.9 |
|---|
| Operating margin | 18.2% | 18.8% | 21.3% | 1.0% | 13.7% | 8.3% |
|---|
| Other income | 7.5 | 2.5 | 1.1 | 1.3 | 1.5 | 4.6 |
|---|
| Interest | 0.7 | 0.9 | 0.6 | 3.6 | 3.5 | 3.4 |
|---|
| Depreciation | 0.8 | 0.5 | 0.8 | 0.9 | 1.4 | 1.3 |
|---|
| Profit before tax | 10.3 | 17.3 | 21.3 | −2.3 | 7.8 | 8.8 |
|---|
| Tax | 5.2 | 3.4 | 2.0 | 4.9 | 4.0 | 8.0 |
|---|
| Net profit | 5.0 | – | 0.1 | −7.1 | 3.8 | 0.8 |
|---|
| EPS (₹) | 0.77 | – | 0.30 | -0.11 | 0.06 | 0.01 |
|---|
₹ crore, financial years to March.
| Line | FY26 |
|---|---|
| Sales | 309 |
| Expenses | 266 |
| Operating profit | 43.1 |
| Operating margin | 14.0% |
| Other income | 12.3 |
| Interest | 5.8 |
| Depreciation | 3.0 |
| Profit before tax | 46.6 |
| Tax | 15.3 |
| Net profit | 31.0 |
| EPS (₹) | 0.48 |
₹ crore, at each year's end and the latest half year.
₹ crore, by financial year, and the latest half year.
| Line | FY26 | 6M to Sep 2026 |
|---|---|---|
| From operations | −138 | 9.3 |
| From investing | 10.5 | −2.5 |
| From financing | 34.6 | 44.5 |
| Spent on fixed assets | −9.6 | −11.2 |
| Free cash flow | −147 | −1.9 |
Margins, returns, debt, tax and cash.
| Line | FY26 |
|---|---|
| Net margin | 10.1% |
| Operating margin | 14.0% |
| Return on equity | 8.0% |
| Return on capital employed | 11.4% |
| Return on assets | 4.6% |
| Debt to equity | 0.19 |
| Interest coverage | 9.00 |
| Debt to assets | 0.11 |
| Current ratio | 1.60 |
| Quick ratio | 1.55 |
| Cash ratio | 0.05 |
| Asset turnover | 0.46 |
| Fixed asset turnover | 24.73 |
| Inventory turnover | 11.30 |
| Receivables turnover | 1.10 |
| Gross margin | 53.8% |
| Cash from operations to profit | -444.0% |
| Effective tax rate | 32.9% |
A copy Scrutinizers report of Annual General Meeting held on September 29, 2026. Further, the company has informed the Exchange regarding voting results.
Proceedings of Annual General Meeting held on September 29, 2026
Corrigendum to Annual Report FY 2025-26
Outcome of Board Meeting held on September 24, 2026.
Presentation of Investor/Analyst meeting
Chairman's Letter to Shareholders
Presentation
Schedule of meet
Outcome of Board Meeting held on September 03, 2026.